The Cancer Letter (Mar 20, 2020): COVID-19 and Cancer Consortium

Nature Cancer (Apr 21, 2020): Desai et al. Crowdsourcing a crisis response for COVID-19 in Oncology

Cancer Cell (Apr 27, 2020): Rubinstein et al. The COVID-19 & Cancer Consortium (CCC19): a collaborative effort to understand the effects of COVID-19 on patients with cancer

Advances in Radiation Oncology (October 29, 2020): Jhawar et al. The COVID-19 and Cancer Consortium (CCC19) and Opportunities for Radiation Oncology

ESMO Open (June 19, 2023): Castelo-Branco et al. Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology—shared perspectives from international consortia

DRYAD (February 20, 2023): Covid-19 and Cancer Consortium (CCC19) breast cancer and racial disparities outcomes study

ASCO 2020 LBA110 (Warner; May 28, 2020): Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)

ISTH 2020 Congress (Rosovsky; July 12-14, 2020): Venous Thrombotic Complications in Cancer Patients with SARS-CoV-2 Infection: Report from the COVID-19 and Cancer Consortium (CCC19) Registry Analysis

AACR COVID-19 and Cancer virtual meeting (Peters; July 21, 2020): Flexibility to sustain solidity: Addressing new vulnerabilities in cancer at the time of COVID-19

AACR COVID-19 and Cancer virtual meeting (Rini; July 22, 2020): Understanding the impact of COVID in cancer patients through the COVID-19 and Cancer (CCC19) and other COVID consortiums

ESMO 2020 LBA71 (Wise-Draper; Sep 19, 2020): Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis

ESMO 2020 LBA72 (Grivas; Sep 20, 2020): Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19)

ASH 2020 # 1632 (Rubisntein; Dec 5, 2020): Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis

ASH 2020 #204 (Li; Dec 5, 2020): Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry

SABC 2021 #PS7-01 (Khaki; Dec, 2020): Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and cancer consortium (CCC19) cohort study

ASCO-GU 2021 #39 (Tucker; Feb 2021): Severe-COVID-19 and mortality among patients (pts) with prostate cancer (PCa) receiving androgen deprivation therapy (ADT).

ACC 2021 (Moey; May 16, 2021): Clinical characteristics and outcomes in cardio-oncology patients with covid-19: analysis from the covid-19 and cancer consortium (CCC19) database

ASCO 2021 #4529 (Schmidt; June, 2021): Effect of Bacillus Calmette-Guerin (BCG) exposure on severity of COVID-19 infection: A COVID-19 and Cancer Consortium (CCC19) study

ASCO 2021 #6500 (Nagaraj; June, 2021): Racial and ethnic disparities among patients with breast cancer and COVID-19

ASCO 2021 #6561 (Enriquez; June, 2021): Concomitant infections in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study

ASCO 2021 #6563 (Shah; June, 2021): Lower respiratory tract disease (LRTD) in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study

ASCO 2021 #12035 (Loggers; June, 2021): Code status and outcomes in patients with cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) registry analysis

ASCO 2021 #e18788 (Gulati; June, 2021): Thrombotic complications with SARS-CoV-2 infection in patients with cancer on high-risk therapies: Data from the COVID-19 and Cancer Consortium (CCC19)

ASCO 2021 #11523 (Wagner; June, 2021): Demographics, outcomes, and risk factors for patients (Pts) with sarcoma and COVID-19: A multi-institutional cohort analysis.

ASH 2021 #154314 (Shah; Nov, 2021): Bleeding complications in patients with Cancer and COVID 19 - Analysis from the COVID 19 and Cancer consortium (CCC19) Registry

ASCO 2022 #6031 (Karivedu; June, 2022): Complications and severity of COVID-19 in patients with head and neck cancer (HNC): A COVID-19 and Cancer Consortium (CCC19) registry analysis

ASCO 2022 #5508 (Beeghly-Fadiel; June, 2022): COVID-19 in Patients with Gynecologic Cancer: A Preliminary Report from the COVID-19 and Cancer Consortium (CCC19)

ASCO 2022 #e18766 (Kulkarni; June, 2022): Smoking and COVID-19 in patients with cancer: Novel analysis from CCC19 registry.

ASCO 2022 #e18790 (Subbiah; June, 2022): COVID-19 Outcomes in Patients with Cancer and HIV: An Analysis of the COVID-19 and Cancer Consortium (CCC19)

ASCO 2022 #e18746 (Warner; June, 2022): Post-Acute Sequelae of SARS-CoV-2 Infection in Patients with Cancer

ASCO 2022 #10565 (Shah; June, 2022): An update on the overall epidemiology, clinical characteristics, and outcomesfrom the COVID-19 and Cancer Consortium (CCC19)

WCLC 2022 #OA06.06 (Kulkarni; August, 2022): Impact of Systemic Anti-cancer Treatments on Outcomes of COVID-19 in Patients with Thoracic Cancers: CCC19 Registry Analysis

ESMO 2022 (Halabi; September, 2022): 501P - A prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19

ESMO 2022 (Bakouny; September, 2022): 502P - Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer

NIH Office of Data Science Strategy Data Sharing and Reuse Seminar (February, 2024): COVID-19 and Cancer: Catalyzing Collaboration; Seminar Recording

Cancer Cell (November 2020): Bakouny et al. COVID-19 and Cancer: Current Challenges and Perspectives

JAMA Oncology (September 2021): Desai, Mohammed et al. COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response

Cancer Discovery (December 2021): Elkrief et al. Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer

ESMO Open (June 19, 2023): Castelo-Branco et al. Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology—shared perspectives from international consortia

AACR Blog (Mar 25, 2020): COVID-19 and Cancer Consortium Forms to Collect and Share Information

The Cancer Letter (May 22, 2020): CCC19 bridging the knowledge gap for patients with COVID-19 and cancer

The Cancer Letter (May 29, 2020): CCC19 data point to extensive use of hydroxychloroquine, azithromycin, or both, by patients with cancer and COVID-19

The Lancet (May 29, 2020): Cancer and COVID-19: what do we really know?

JCO Clinical Cancer Informatics (June 17, 2020): Crowdsourcing in Crisis: Rising to the Occasion

The Cancer Letter (March 19, 2021): The COVID-19 and Cancer Consortium - A year into building a United Front against the SARS-CoV-2 pandemic

Cancer Cell (April 15, 2021): Care without a compass: including patients with cancer in COVID-19 studies

Journal of the National Cancer Institute (August 28, 2021): COVID-19 Vaccine among Actively-Treated People with Cancer: A Glimpse into the Known Unknowns?

OncLive (Mar 18, 2020): Cancer Registry Launches to Inform COVID19+ Patient Demographics

Cancer Network (Mar 20, 2020): CCC19 Registry Launched to Understand COVID-19 in Patients with Cancer

ASCO Daily News (Mar 25, 2020): The Blind Leading the Blind: COVID19, Cancer, and the Need for more data

Urotoday (Mar 25, 2020): COVID19 and Cancer Consortium (CCC19)

ASCO Daily News (Mar 26, 2020): Cancer Consortium Launches COVID19 Registry in Urgent Appeal for Data to Save Lives at Risk from Infection

ASCO Post (Mar 27, 2020): The Blind Leading the Blind: COVID19, Cancer, and the Need for more data

Medicine Matters Oncology (Mar 27, 2020): COVID-19 cancer registry launched in the USA

Onconews, Brazil (Mar 28, 2020): Intitative gathers data on COVID-19 and cancer

Practice Update (Apr 1, 2020): Immediate Impact of COVID-19 on Cancer Care at Major Institutions

SWOG: The Front Line (Apr 3, 2020): COVID Registry gets its start on Twitter

ASH Clinical News (Apr 9, 2020): COVID19, Cancer and Need for Clarity

British Medical Journal News (Apr 17,2020): COVID19 is shattering US cancer care

OncLive (Apr 18,2020): COVID19 and Cancer Consortium Gains International Ground

Frontline (May 4,2020): As Pandemic claims non-COVID patients, some face difficult decisions

Cancer Therapy Advisor (May 7, 2020): Researchers Turn to Crowdsourcing To Learn More About COVID19 and Cancer

Associated Press (May 28, 2020): Cancer, coronavirus are a dangerous mix, new studies find

Cancer Network (May 28, 2020): Cancer Progression Linked to Increased Risk of Death within 30 days of COVID19 diagnosis

CNN (May 28, 2020): How having cancer can put Covid-19 patients at higher risk of dying

MedPageToday (May 28, 2020): HCQ Linked to Harm in Cancer Patients

Reuters Health News (May 28, 2020): Hydroxychloroquine combination risky for cancer patients with COVID19

USA Today (May 28,2020): New study shows more cancer patients die from COVID19, but not necessarily for the reasons you'd expect

Wall Street Journal (May 28, 2020): Higher Death Rates Found Among Cancer Patients with COVID19

Medscape (May 29, 2020): Active Cancer Increases Death Risk in Patients With COVID-19

The Financial Express (May 30, 2020): Death Risk higher in cancer patients

Healthline (June 9, 2020): People with Cancer Have to Choose Between Treatment and COVID-19 Risks

ASCO Post (June 12, 2020): Factors Associated With All-Cause 30-Day Mortality in Patients With Cancer Infected With COVID-19: CCC19 Database Analysis

Medscape (June 17, 2020): From a Tweet to the Lancet in 10 Weeks: COVID-Cancer Consortium

ASCO Post (June 24, 2020): Results of a COVID19 and Cancer Consortium (CCC19) Cohort Study

ASCO Post (June 25, 2020): COVID19 and Patients with Cancer: A Call to Action for Trainees

Medscape (July 27, 2020): CCC19, Other Registries Help Define COVID-19/Cancer Landscape

Elemental by Medium (August 5, 2020): The Unique Devastation of Cancer in a Pandemic

Healio (August 5, 2020): Hydroxychloroquine regimens for COVID-19 linked to mortality risk for patients with cancer

Cancer Therapy Advisor (August 12, 2020): The Twitter Effect on How Oncologists Conduct and Share Research

VUMC Reporter (Feb. 5, 2021): Convalescent plasma improved survival in COVID-19 patients with blood cancers

UroToday (March 22, 2021): COVID-19 and Cancer Consortium Study Highlights Increased Mortality and Racial Disparities for Patients with Cancer Diagnosed with SARS-CoV-2 Infection

Onconews, Brazil (March 23, 2021): CCC19: Clinical factors, cancer treatment and severity of COVID-19 in cancer patients

UT Health News (June 17, 2021): Blood cancer patients with COVID-19 fare better with convalescent plasma

Washington University School of Medicine News (June 17, 2021): Blood cancer patients with COVID-19 fare better with convalescent plasma

The Milwaukee Journal Sentinel (July 7, 2021): Plasma from recovered COVID patients shows remarkable effectiveness for patients with coronavirus, blood cancer

Cancer Therapy Advisor (November 15, 2021): High Rate of Complications Reported in Sarcoma Patients With COVID-19

NBC 10 News (January 11, 2022): Cancer patients with breakthrough COVID at high risk for hospitalization

EurekaAlert (November 3, 2022): Study examines immunotherapy’s effect on COVID-19 outcomes

medicalxpress (November 3, 2022): Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

MedPage Today (August 17, 2023): Clot Risk Factors Emerge for Cancer Patients With COVID-19

Cancer Therapy Advisor (August 21, 2023): Systemic Therapies May Increase Risk of VTE in Patients With Cancer and COVID-19

Providence Business News (November 26, 2023): Five Questions With: Sanjay Mishra

Center for Biomedical Informatics and Information Technology (CBIIT) News (February 28, 2024): COVID-19 and Cancer Consortium Wins the NIH/FASEB DataWorks! Prize Challenge

ASCO Daily News (Mar 27, 2020): COVID19: How to Care for Patients With Cancer In a Global Pandemic

OncLive (Mar 30, 2020): Collaborative efforts lead to launch of COVID19 and Cancer Consortium registry

The Video Journal of Oncology (May 30, 2020): CCC19: COVID-19 and cancer

Practice Update (Mar 30, 2020): COVID19 registry for cancer patients: Rationale

IDSA COVID 19 Podcast (Apr 1, 2020): COVID19: What's Happening Now?

VuMedi (Apr 1, 2020): COVID-19 Pandemic: Preparation Protocols, Telemedicine and Modifying Treatment for Cancer Patients

eCancer (Apr 9, 2020): How COVID19 is impacting cancer patient care and clinical research

VuMedi (Apr 17, 2020): What is the COVID19 Cancer Consortium? Urgent need to generate knowledge on COVID19

OncLive (Apr 20, 2020): Dr. Choueiri on COVID19 and Cancer Consortium

Onconews (Apr 26, 2020): Crowdsourcing, COVID-19 and oncology

eCancer (May 13, 2020): The COVID19 and Cancer Consortium

Onconews (May 29, 2020): Global consortium shows results on cancer and COVID-19

Uromigos (May 29, 2020): Episode 27: COVID-19 in > 1000 Cancer Patients with Jeremy Warner (CCC19)

CancerNetwork (May 29, 2020): Petros Grivas, MD, PhD, on the Future of the CCC19 Registry

VJOncology (May 30, 2020): CCC19: COVID-19 and cancer

ecancer (31 May, 2020): Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)

Medicine Matters Oncology (1 June, 2020): Initial data from CCC19

CancerNetwork (July 28, 2020): Jeremy L. Warner, MD, MS, on Updated Findings from the COVID-19 and Cancer Consortium

OnLive (August 14, 2020): Dr. Choueiri on the Significance of the CCC19 During the COVID-19 Crisis

Oncology Learning Network (Aug 18, 2020): Dr Lyman and Dr Desai Talk COVID-19, Cancer Care, and the CCC19 Initiative

OBRoncology (Sep 24, 2020): Petros Grivas, MD, PhD, discusses the COVID-19 and Cancer Consortium (CCC19) from ESMO 2020

VJOncology (Oct 2, 2020): CCC19: assessment of clinical and laboratory prognostic factors

VJOncology (Oct 5, 2020): CCC19: systemic cancer treatment-related outcomes

VuMedi (May 20, 2021): COVID-19 Severity Among Patients with Cancer (2021 Analysis): Which Anti-Cancer Drugs and Regimens Have High Associated Mortality?